These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

815 related items for PubMed ID: 25501614

  • 41. An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis.
    Dolling DI, Desai M, McOwan A, Gilson R, Clarke A, Fisher M, Schembri G, Sullivan AK, Mackie N, Reeves I, Portman M, Saunders J, Fox J, Bayley J, Brady M, Bowman C, Lacey CJ, Taylor S, White D, Antonucci S, Gafos M, McCormack S, Gill ON, Dunn DT, Nardone A, PROUD Study Group.
    Trials; 2016 Mar 24; 17():163. PubMed ID: 27013513
    [Abstract] [Full Text] [Related]

  • 42. Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial.
    Celum C, Morrow RA, Donnell D, Hong T, Hendrix CW, Thomas KK, Fife KH, Nakku-Joloba E, Mujugira A, Baeten JM, Partners PrEP Study Team.
    Ann Intern Med; 2014 Jul 01; 161(1):11-9. PubMed ID: 24979446
    [Abstract] [Full Text] [Related]

  • 43. Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial.
    Wang H, Wang Z, Huang X, Chen Y, Wang H, Cui S, Zhang J, Chu Z, Hu Q, Ding H, Qian H, Zou H, Tang W, Gao Y, Jin X, Liu Z, Zhang L, Zhao J, He X, Jiang Y, Geng W, Xu J, Shang H, China Real-World Oral Intake of PrEP (CROPrEP) Study Team.
    JAMA Netw Open; 2022 Feb 01; 5(2):e2148782. PubMed ID: 35171258
    [Abstract] [Full Text] [Related]

  • 44. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.
    Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Priddy FH.
    PLoS One; 2012 Feb 01; 7(4):e33103. PubMed ID: 22511916
    [Abstract] [Full Text] [Related]

  • 45. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.
    Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, Mujugira A, Mugo N, Ndase P, Hendrix C, Celum C.
    J Acquir Immune Defic Syndr; 2014 Jul 01; 66(3):340-8. PubMed ID: 24784763
    [Abstract] [Full Text] [Related]

  • 46. HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project.
    Sullivan PS, Phaswana-Mafuya N, Baral SD, Valencia R, Zahn R, Dominguez K, Yah CS, Jones J, Kgatitswe LB, McNaghten AD, Siegler AJ, Sanchez TH, Bekker LG.
    J Int AIDS Soc; 2020 Oct 01; 23 Suppl 6(Suppl 6):e25591. PubMed ID: 33000918
    [Abstract] [Full Text] [Related]

  • 47. Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models.
    van de Vijver DA, Nichols BE, Abbas UL, Boucher CA, Cambiano V, Eaton JW, Glaubius R, Lythgoe K, Mellors J, Phillips A, Sigaloff KC, Hallett TB.
    AIDS; 2013 Nov 28; 27(18):2943-51. PubMed ID: 23939237
    [Abstract] [Full Text] [Related]

  • 48. Does HIV Pre-Exposure Prophylaxis Modify the Effect of Partnership Characteristics on Condom Use? A Cross-Sectional Study of Sexual Partnerships Among Men Who Have Sex with Men in San Francisco, California.
    Prescott MR, Hern J, Petersen M, Santos GM.
    AIDS Patient Care STDS; 2019 Apr 28; 33(4):167-174. PubMed ID: 30932698
    [Abstract] [Full Text] [Related]

  • 49. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
    McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, Sullivan AK, Clarke A, Reeves I, Schembri G, Mackie N, Bowman C, Lacey CJ, Apea V, Brady M, Fox J, Taylor S, Antonucci S, Khoo SH, Rooney J, Nardone A, Fisher M, McOwan A, Phillips AN, Johnson AM, Gazzard B, Gill ON.
    Lancet; 2016 Jan 02; 387(10013):53-60. PubMed ID: 26364263
    [Abstract] [Full Text] [Related]

  • 50. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis.
    Tang EC, Vittinghoff E, Philip SS, Doblecki-Lewis S, Bacon O, Chege W, Coleman ME, Elion R, Buchbinder S, Kolber MA, Liu AY, Cohen SE.
    AIDS; 2020 Jul 01; 34(8):1181-1186. PubMed ID: 32205724
    [Abstract] [Full Text] [Related]

  • 51. HIV preexposure prophylaxis: new data and potential use.
    Celum CL.
    Top Antivir Med; 2011 Dec 01; 19(5):181-5. PubMed ID: 22298887
    [Abstract] [Full Text] [Related]

  • 52. Same-Day Initiation of Oral Pre-Exposure Prophylaxis is High Among Adolescent Men Who Have Sex With Men and Transgender Women in Brazil.
    Soares F, Magno L, Pinto JA, Grangeiro A, Bruxvoort K, Greco D, Dourado I.
    J Adolesc Health; 2023 Dec 01; 73(6S):S26-S32. PubMed ID: 37953005
    [Abstract] [Full Text] [Related]

  • 53. Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017.
    Finlayson T, Cha S, Xia M, Trujillo L, Denson D, Prejean J, Kanny D, Wejnert C, National HIV Behavioral Surveillance Study Group.
    MMWR Morb Mortal Wkly Rep; 2019 Jul 12; 68(27):597-603. PubMed ID: 31298662
    [Abstract] [Full Text] [Related]

  • 54. Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru.
    Tang EC, Sobieszczyk ME, Shu E, Gonzales P, Sanchez J, Lama JR.
    AIDS Res Hum Retroviruses; 2014 May 12; 30(5):416-24. PubMed ID: 24319983
    [Abstract] [Full Text] [Related]

  • 55. Preexposure prophylaxis for the prevention of HIV transmission to women.
    Aaron E, Cohan D.
    AIDS; 2013 Jan 02; 27(1):F1-5. PubMed ID: 22914582
    [Abstract] [Full Text] [Related]

  • 56. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, van Duijnhoven YTHP, Bruisten S, Oostvogel P, Davidovich U, Hogewoning A, Prins M, de Vries HJC, Amsterdam PrEP Project team in the HIV Transmission Elimination AMsterdam (H-TEAM) Initiative.
    Lancet HIV; 2019 Jul 02; 6(7):e447-e455. PubMed ID: 31178284
    [Abstract] [Full Text] [Related]

  • 57. Preference for daily versus on-demand pre-exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real-world Oral PrEP Demonstration study.
    Zhang J, Xu JJ, Wang HY, Huang XJ, Chen YK, Wang H, Chu ZX, Hu QH, He XQ, Li Y, Zhang LK, Hu ZL, Bao RT, Li SC, Li H, Ding HB, Jiang YJ, Geng WQ, Sylvia S, Shang H, CROPrEP Group.
    J Int AIDS Soc; 2021 Feb 02; 24(2):e25667. PubMed ID: 33586841
    [Abstract] [Full Text] [Related]

  • 58. Adherence to PrEP Among Young Men Who Have Sex With Men Participating in a Sexual Health Services Demonstration Project in Alameda County, California.
    Myers JJ, Kang Dufour MS, Koester KA, Udoh I, Frazier R, Packard R, Kennedy K, Erguera X, Horowitz J, Grant R, Burack JH.
    J Acquir Immune Defic Syndr; 2019 Aug 01; 81(4):406-413. PubMed ID: 30973542
    [Abstract] [Full Text] [Related]

  • 59. Perceived need of, and interest in, HIV pre-exposure prophylaxis amongst men who have sex with men attending three sexual health clinics in London, UK.
    Bull L, Dimitrijevic P, Beverley S, Scarborough A, Mandalia S, Dosekun O, Barber T, Reeves I, McCormack S, Rayment M.
    Int J STD AIDS; 2018 Apr 01; 29(5):435-442. PubMed ID: 28927341
    [Abstract] [Full Text] [Related]

  • 60. Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial.
    Mugo NR, Hong T, Celum C, Donnell D, Bukusi EA, John-Stewart G, Wangisi J, Were E, Heffron R, Matthews LT, Morrison S, Ngure K, Baeten JM, Partners PrEP Study Team.
    JAMA; 2018 Apr 01; 312(4):362-71. PubMed ID: 25038355
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.